mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.091 |
0.06 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.06 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.092 |
0.06 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.06 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.06 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.06 |